Evidence map›Paper›PMID 37854922›Full record

ArticleJournal of oral and maxillofacial pathology : JOMFP

An interesting case-report of ex-ameloblastic carcinoma.

Sanjeev Tomar, Upma Tomar, Richa Singh, Nancy Verma

Open access · hybridAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of oral and maxillofacial pathology : JOMFP. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sanjeev TomarDepartment of Oral and Maxillofacial Surgery, Santosh Dental College, Santosh Deemed to be University, Ghaziabad, Uttar Pradesh, India.
Upma TomarDepartment of Oral and Maxillofacial Pathology and Microbiology, Inderprastha Dental College, Ghaziabad, Uttar Pradesh, India.
Richa SinghDepartment of Oral and Maxillofacial Pathology and Microbiology, Santosh Dental College, Santosh Deemed to be University, Ghaziabad, Uttar Pradesh, India.
Nancy VermaDepartment of Oral and Maxillofacial Pathology and Microbiology, Santosh Dental College, Santosh Deemed to be University, Ghaziabad, Uttar Pradesh, India.
Santosh University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ameloblastoma (AM) is considered one of the most common lesions of odontogenic origin. Although it is always considered as benign neoplasm, ameloblastic carcinoma (AC) represents its malignant counterpart. It is characterized by the expansion of jaws, rapid growth, and a perforated cortex with well-defined unilocular/multilocular radiolucent lesions. To confirm the diagnosis of AM and AC is extremely crucial. Immunohistochemistry such as SOX2 and Ki67 plays a significant role in the confirmation of diagnosis. Management of these cases is from surgical excision with radical neck dissection. The prognosis is poor with only 5 years of survival. This review presents an interesting case of ex-AC, in which the patient was diagnosed at the same site with peripheral AM 1 year ago.

Indexed as

Ameloblastomaex-ameloblastic carcinomaKi67odontogenic tumorsSOX2

Identifiers

PMID37854922
PMCPMC10581286
OpenAlexW4387764902

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.